|
| Exchange Disseminated Time | Lincoln Pharmaceuticals Ltd has informed BSE that the Company is going to set up USFDA plant near by Ahmedabad city at a total approx cost of Rs. 50 Crores.
LPL is strengthening his international business by way of setting up USFDA plant for Oral formulation for regulatory market like USA, U.K., Europe, Brazil, South Africa. By setting up this plant, this will greatly supports for gearing up the manufacturing facility for regulatory approvals starting to validation activities. This will also greatly help to the Company for better sustainable organization growth through creating strong regulatory and R&D strategies, product pipeline and identifying the business opportunities in future.
The Company has planned to achieve the Top line of Rs. 200 Crores with a bottom-line of Rs. 20 Crores year with EPS of Rs. 17/- per share for the current financial year. |
|
|